JP2021513077A5 - - Google Patents
Info
- Publication number
- JP2021513077A5 JP2021513077A5 JP2020542645A JP2020542645A JP2021513077A5 JP 2021513077 A5 JP2021513077 A5 JP 2021513077A5 JP 2020542645 A JP2020542645 A JP 2020542645A JP 2020542645 A JP2020542645 A JP 2020542645A JP 2021513077 A5 JP2021513077 A5 JP 2021513077A5
- Authority
- JP
- Japan
- Prior art keywords
- dementia
- subject
- adm
- level
- adrenomedullin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023174585A JP2024001208A (ja) | 2018-02-08 | 2023-10-06 | 認知症の診断および/または予測のためのアドレノメデュリン(adm)、ならびに認知症の治療または予防における使用のための抗アドレノメデュリンバインダー |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18155682 | 2018-02-08 | ||
| EP18155682.0 | 2018-02-08 | ||
| PCT/EP2019/052982 WO2019154900A1 (en) | 2018-02-08 | 2019-02-07 | Adrenomedullin (adm) for diagnosis and/or prediction of dementia and anti-adrenomedullin binder for use in therapy or prevention of dementia |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023174585A Division JP2024001208A (ja) | 2018-02-08 | 2023-10-06 | 認知症の診断および/または予測のためのアドレノメデュリン(adm)、ならびに認知症の治療または予防における使用のための抗アドレノメデュリンバインダー |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021513077A JP2021513077A (ja) | 2021-05-20 |
| JP2021513077A5 true JP2021513077A5 (cg-RX-API-DMAC7.html) | 2022-08-04 |
Family
ID=61188647
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542645A Pending JP2021513077A (ja) | 2018-02-08 | 2019-02-07 | 認知症の診断および/または予測のためのアドレノメデュリン(adm)、ならびに認知症の治療または予防における使用のための抗アドレノメデュリンバインダー |
| JP2023174585A Pending JP2024001208A (ja) | 2018-02-08 | 2023-10-06 | 認知症の診断および/または予測のためのアドレノメデュリン(adm)、ならびに認知症の治療または予防における使用のための抗アドレノメデュリンバインダー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023174585A Pending JP2024001208A (ja) | 2018-02-08 | 2023-10-06 | 認知症の診断および/または予測のためのアドレノメデュリン(adm)、ならびに認知症の治療または予防における使用のための抗アドレノメデュリンバインダー |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20210302440A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3749959A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2021513077A (cg-RX-API-DMAC7.html) |
| KR (1) | KR102717599B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN119770645A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019219071A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112020014940A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3090736A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL276564A (cg-RX-API-DMAC7.html) |
| MX (1) | MX421834B (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202006686SA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019154900A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4110372A1 (en) * | 2020-02-26 | 2023-01-04 | PAM Theragnostics GmbH | Use of peptidylglycine alpha-amidating monooxygenase (pam) for therapeutic purpose |
| EP3871689A1 (en) * | 2020-02-26 | 2021-09-01 | sphingotec GmbH | Anti-adm-antibodies binding to the free n-terminus for accelerated transition of adm-gly to bio-adm in patients with adm-gly/ bio-adm ratio above a threshold and combination with vitamin c |
| JP2023515981A (ja) | 2020-02-26 | 2023-04-17 | ペーアーエム セラノスティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング | ペプチジルグリシンαアミド化モノオキシゲナーゼ(PAM)を決定する方法および診断目的でのその使用 |
| US20210285949A1 (en) | 2020-03-16 | 2021-09-16 | Sphingotec Gmbh | Pro-adrenomedullin or fragment thereof in patients infected with corona virus and treatments with binder against adrenomedullin |
| EP4680966A1 (en) | 2023-03-17 | 2026-01-21 | PAM Theragnostics GmbH | Methods for determining peptidylglycine alpha-amidating monooxygenase (pam) and its use for diagnostic purpose |
| WO2025133203A1 (en) | 2023-12-22 | 2025-06-26 | Pam Theragnostics Gmbh | Compounds and methods for a long-lasting pam |
| WO2025133225A1 (en) | 2023-12-22 | 2025-06-26 | Pam Theragnostics Gmbh | Pharmaceutical combination of peptide-gly and peptidylglycine alpha-amidating monooxygenase (pam) |
| WO2026099249A1 (en) | 2024-11-05 | 2026-05-15 | Pam Theragnostics Gmbh | Modified and unmodified peptidylglycine alpha-amidating monooxygenase (pam) for use in subjects having increased amyloid-beta and/or phospho-tau-protein load and/or neuroinflammation |
| WO2026099243A1 (en) | 2024-11-05 | 2026-05-15 | Pam Theragnostics Gmbh | Modified and unmodified peptidyl-glycine alpha-amidating monooxygenase (pam) for use in the treatment or prevention of cerebral hypoperfusion for the improvement of cerebral blood flow (cbf) |
| WO2026132535A1 (en) | 2024-12-20 | 2026-06-25 | B.R.A.H.M.S Gmbh | Pro-adrenomedullin and fragment(s) thereof for diagnosis and/or prognosis of a central nervous system inflammation |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| AU634716B2 (en) | 1988-08-01 | 1993-03-04 | Ciba Corning Diagnostics Corp. | Method for detection of an analyte using acridinium esters and liposomes |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| EP1690935A3 (en) | 1990-01-12 | 2008-07-30 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| ES2139598T3 (es) | 1990-07-10 | 2000-02-16 | Medical Res Council | Procedimientos para la produccion de miembros de parejas de union especifica. |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| JPH07503132A (ja) | 1991-12-17 | 1995-04-06 | ジェンファーム インターナショナル,インコーポレイティド | 異種抗体を産生することができるトランスジェニック非ヒト動物 |
| JP2774769B2 (ja) | 1993-04-26 | 1998-07-09 | 賢治 寒川 | アドレノメデュリン |
| US6818418B1 (en) | 1998-12-10 | 2004-11-16 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| CN1628126A (zh) | 2001-08-30 | 2005-06-15 | 比奥雷克西斯药物公司 | 经修饰的运铁蛋白融合蛋白 |
| CA2543360A1 (en) | 2003-10-24 | 2005-05-06 | Joost A. Kolkman | Ldl receptor class a and egf domain monomers and multimers |
| US20100028995A1 (en) | 2004-02-23 | 2010-02-04 | Anaphore, Inc. | Tetranectin Trimerizing Polypeptides |
| AU2005287557B2 (en) | 2004-09-21 | 2011-10-13 | Biontech Ag | Use of microproteins as tryptase inhibitors |
| DE102005036094A1 (de) * | 2005-08-01 | 2007-02-08 | B.R.A.H.M.S Ag | In vitro Verfahren zur Diagnose von neurodegenerativen Erkrankungen |
| US20090306227A1 (en) | 2005-08-31 | 2009-12-10 | Toshiyuki Ioka | Tablet for removing tongue coating |
| DE102006027818A1 (de) * | 2006-06-16 | 2007-12-20 | B.R.A.H.M.S. Aktiengesellschaft | In vitro Multiparameter-Bestimmungsverfahren zur Diagnose und Frühdiagnose von neurodegenerativen Erkrankungen |
| DE102006060112A1 (de) | 2006-12-20 | 2008-06-26 | Brahms Aktiengesellschaft | Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM |
| ES2373832T3 (es) | 2007-12-19 | 2012-02-09 | Affibody Ab | Polipéptido derivado de proteína a y capaz de unirse a pdgf. |
| WO2009095454A2 (de) * | 2008-02-01 | 2009-08-06 | Brahms Aktiengesellschaft | Verfahren zur identifizierung von therapiebedürftigen patienten mit leichten kognitiven störungen und die behandlung derartiger patienten |
| NZ592591A (en) | 2008-11-03 | 2012-04-27 | Molecular Partners Ag | Binding proteins comprising ankyrin repeast domains that inhibit the vegf-a receptor interaction |
| CA2772162C (en) | 2009-08-27 | 2018-05-22 | Covagen Ag | Anti-il-17a fynomers and medical uses thereof |
| BR112012014417B1 (pt) | 2009-12-14 | 2021-11-09 | Scil Proteins Gmbh | Proteínas ubiquitinas modificadas tendo uma atividade de ligação específica para o extradomínio b de fibronectina |
| AU2011263786B2 (en) | 2010-06-08 | 2014-11-13 | Astrazeneca Ab | Tear lipocalin muteins binding IL-4 R alpha |
| FR2964103B1 (fr) * | 2010-08-30 | 2018-11-23 | Universite D'aix-Marseille | Anticorps se liant a l'adrenomedulline et aux recepteurs de l'adrenomedulline et leurs utilisations comme medicament |
| BR112014011670B1 (pt) * | 2011-11-16 | 2021-05-25 | Adrenomed Ag | anticorpo anti-adrenomedulina (adm) ou fragmento de anticorpo anti-adm ou um arcabouço de proteína não-igg anti-adm que se liga à adrenomedulina e formulação farmacêutica |
| US9140696B2 (en) | 2011-11-16 | 2015-09-22 | Adrenomed Ag | Anti-adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-IG scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition |
| US20160230227A1 (en) * | 2012-12-21 | 2016-08-11 | The New York Stem Cell Foundation | Methods of treating alzheimer's disease |
| CN109716136B (zh) * | 2016-07-08 | 2023-09-22 | 斯弗因高泰克有限公司 | 肾上腺髓质素用于评估急性心力衰竭患者的充血 |
-
2019
- 2019-02-07 KR KR1020207025729A patent/KR102717599B1/ko active Active
- 2019-02-07 AU AU2019219071A patent/AU2019219071A1/en not_active Abandoned
- 2019-02-07 JP JP2020542645A patent/JP2021513077A/ja active Pending
- 2019-02-07 US US16/968,483 patent/US20210302440A1/en active Pending
- 2019-02-07 CA CA3090736A patent/CA3090736A1/en active Pending
- 2019-02-07 BR BR112020014940-3A patent/BR112020014940A2/pt not_active IP Right Cessation
- 2019-02-07 CN CN202411684173.XA patent/CN119770645A/zh active Pending
- 2019-02-07 EP EP19702467.2A patent/EP3749959A1/en active Pending
- 2019-02-07 CN CN201980012542.1A patent/CN111902721B/zh active Active
- 2019-02-07 MX MX2020008345A patent/MX421834B/es unknown
- 2019-02-07 SG SG11202006686SA patent/SG11202006686SA/en unknown
- 2019-02-07 WO PCT/EP2019/052982 patent/WO2019154900A1/en not_active Ceased
-
2020
- 2020-08-06 IL IL276564A patent/IL276564A/en unknown
-
2022
- 2022-12-30 US US18/148,633 patent/US20230221339A1/en active Pending
-
2023
- 2023-10-06 JP JP2023174585A patent/JP2024001208A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024001208A5 (cg-RX-API-DMAC7.html) | ||
| US12286480B2 (en) | Modulators of ROR1-ROR2 binding | |
| Chanez et al. | Corticosteroid reversibility in COPD is related to features of asthma. | |
| Dropcho | Antiamphiphysin antibodies with small‐cell lung carcinoma and paraneoplastic encephalomyelitis | |
| JP6457463B2 (ja) | 処置方法 | |
| JP2016536332A5 (cg-RX-API-DMAC7.html) | ||
| JP2019533807A5 (cg-RX-API-DMAC7.html) | ||
| Yamaguchi et al. | Enzyme‐linked immunosorbent assay of Pro‐gastrin‐releasing peptide for small cell lung cancer patients in comparison with neuron‐specific enolase measurement | |
| WO2009038689A4 (en) | Compositions and methods for diagnosis and treatment of type 2 diabetes | |
| JP2008535494A5 (cg-RX-API-DMAC7.html) | ||
| JP2017501977A (ja) | 肺高血圧症を治療するための組成物および方法 | |
| JP2017509692A5 (cg-RX-API-DMAC7.html) | ||
| CN115976196B (zh) | ErbB3作为肺动脉高压生物标志物和治疗靶点的应用 | |
| CN110320368A (zh) | 基于trem2的诊断试剂盒及其在帕金森病诊断产品上的应用 | |
| JP2024533873A5 (cg-RX-API-DMAC7.html) | ||
| EP4592679A1 (en) | Use of discoidin domain receptor 2 in diagnosis of neurodegenerative diseases, and related computer readable medium | |
| JP3095784B2 (ja) | 炎症プロセスの病因を決定するための診断方法 | |
| WO2016065877A1 (zh) | Cd166作为肝癌诊断血清标志物的应用及其试剂盒 | |
| KR102592460B1 (ko) | 폐동맥고혈압 동물모델 및 이를 이용한 폐동맥고혈압 예방 또는 치료용 물질의 스크리닝 방법 | |
| JP2023544620A5 (cg-RX-API-DMAC7.html) | ||
| CN118203565A (zh) | 去甲替林治疗纤维化疾病的药物用途 | |
| CN120285174A (zh) | 抗vegf抗体与parp抑制剂联合用于治疗肿瘤 | |
| WO2021221668A1 (en) | Anti-sars-cov-2 monoclonal antibody compositions | |
| WO2024090571A1 (ja) | Mmp12を指標とした免疫介在性炎症性疾患の診断、及びmmp12阻害による免疫介在性炎症性疾患の治療用医薬 | |
| WO2024154832A1 (ja) | 全身性強皮症の検出方法 |